1. A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study. (November 2022) Authors: Miglietta, F.; Ragazzi, M.; Fernandes, B.; Griguolo, G.; Massa, D.; Bisagni, A.; Bottosso, M.; Porra, F.; Gaudio, M.; Iannaccone, D.; Fassan, M.; Lo Mele, M.; Gasparini, E.; Zarrilli, G.; Coiro, S.; Dore, L.; Zambelli, A.; Bisagni, G.; Guarneri, V.; Dieci, M.V. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The psychological impact of Stevens–Johnson syndrome and toxic epidermal necrolysis on patients' lives: a Critically Appraised Topic*. (1st September 2020) Authors: O'Reilly, P.; Kennedy, C.; Meskell, P.; Coffey, A.; Delaunois, I.; Dore, L.; Howard, S.; Ramsay, B.; Scanlon, C.; Wilson, D.M.; Whelan, B.; Ryan, S. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗